TNF Receptor-Associated Factor 6 Mediates TNFα-Induced Skeletal Muscle Atrophy in Mice During Aging

Jinbo Li1, Xiangjiao Yi1,2, Zhenqiang Yao1

  • 1Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Insights

Tumor Necrosis Factor-alpha (TNFα) drives age-related and rheumatoid arthritis (RA)-associated sarcopenia by increasing muscle proteolysis and impairing regeneration. Inhibiting TRAF6 signaling offers a potential therapeutic strategy for preventing muscle loss.

Area of Science:

  • Muscle biology
  • Immunology
  • Aging research

Background:

  • Sarcopenia, or age-related muscle loss, is linked to chronic inflammation (inflammaging).
  • Elevated Tumor Necrosis Factor-alpha (TNFα) is observed in sarcopenia-associated conditions like rheumatoid arthritis (RA).
  • The precise role of TNFα in aging and RA-related sarcopenia pathogenesis is unclear.

Purpose of the Study:

  • To investigate the contribution of TNFα to sarcopenia during normal aging and in a mouse model of RA.
  • To elucidate the molecular mechanisms by which TNFα induces muscle atrophy.
  • To explore TRAF6 signaling as a potential therapeutic target.

Main Methods:

  • Comparison of aged wild-type (WT) mice with transgenic (TNF-Tg) mice overexpressing TNFα.
  • Analysis of skeletal muscle characteristics, including cell types, fiber composition, and protein degradation markers.
  • Investigation of TNF receptor-associated factor 6 (TRAF6) signaling pathways and its role in TNFα-induced muscle atrophy.
  • Assessment of the therapeutic potential of TRAF6 haplo-deficiency in preventing sarcopenia.

Main Results:

  • Aged WT mice exhibited increased muscle TNFα, atrophy, reduced satellite cells, and fewer Type IIA myofibers, mirroring TNF-Tg mice.
  • Myeloid cells, including macrophages, showed increased TNFα expression in aged muscles, impairing myogenic differentiation.
  • TRAF6 expression was elevated in aged WT and TNF-Tg mice; TRAF6 mediated TNFα-induced atrophy via NF-κB and muscle-specific E3 ligases (Atrogen1, Murf1).
  • TRAF6 haplo-deficiency in TNF-Tg mice ameliorated muscle atrophy and preserved muscle regeneration.

Conclusions:

  • TNFα contributes significantly to sarcopenia in aging and RA.
  • TRAF6 signaling is a key mediator of TNFα-induced muscle atrophy and regeneration inhibition.
  • Pharmacologic inhibition of TRAF6 in skeletal muscle may offer a therapeutic approach for age- and RA-related sarcopenia.